Immunity https://doi.org/10.1016/j.immuni.2018.05.004 (2018)
Diabetes is often accompanied by hypertension, augmented activation of the sympathetic nervous system (SNS) and inflammation. In Immunity, Dutta and colleagues identify a link between SNS signaling and increased splenic myelopoiesis. Diabetic mice show enhanced splenic myelopoiesis; this results from greater SNS activity and production of catecholamines, which act on granulocyte-macrophage progenitors. Sympathetic nerves signal via neuropeptides to tyrosine hydroxylase–expressing leukocytes. Granulocyte-macrophage progenitors proliferate and differentiate in response to SNS signals, whereas ablation of tyrosine hydroxylase–positive cells, blockade of β2-adrenergic receptors or splenic sympathectomy normalizes the number of myeloid cells in diabetic mice. These findings reveal that neuroimmunological signaling within the spleen results in increased ‘emergency’ myelopoiesis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dempsey, L.A. Triggering myelopoiesis. Nat Immunol 19, 787 (2018). https://doi.org/10.1038/s41590-018-0172-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-018-0172-5